These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29126163)

  • 1. Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
    Chudasama D; Bo V; Hall M; Anikin V; Jeyaneethi J; Gregory J; Pados G; Tucker A; Harvey A; Pink R; Karteris E
    Carcinogenesis; 2018 Mar; 39(3):407-417. PubMed ID: 29126163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway.
    Zhao H; Gao Y; Chen Q; Li J; Ren M; Zhao X; Yue W
    J Cell Mol Med; 2021 Feb; 25(4):1927-1938. PubMed ID: 33314567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole transcriptome signature for prognostic prediction (WTSPP): application of whole transcriptome signature for prognostic prediction in cancer.
    Schaafsma E; Zhao Y; Wang Y; Varn FS; Zhu K; Yang H; Cheng C
    Lab Invest; 2020 Oct; 100(10):1356-1366. PubMed ID: 32144347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
    Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive understanding of ovarian carcinoma survival prognosis by novel biomarkers.
    Wang Y; Lei L; Chi YG; Liu LB; Yang BP
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8257-8264. PubMed ID: 31646556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Bridges AE; Ramachandran S; Pathania R; Parwal U; Lester A; Rajpurohit P; Morera DS; Patel N; Singh N; Korkaya H; Manicassamy S; Prasad PD; Lokeshwar VB; Lokeshwar BL; Ganapathy V; Thangaraju M
    Cancer Res; 2020 Sep; 80(18):3855-3866. PubMed ID: 32665355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.
    Lee M; Nam EJ; Kim SW; Kim S; Kim JH; Kim YT
    Int J Gynecol Cancer; 2012 Nov; 22(9):1489-96. PubMed ID: 23095773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network module-based method for identifying cancer prognostic signatures.
    Wu G; Stein L
    Genome Biol; 2012 Dec; 13(12):R112. PubMed ID: 23228031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
    Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
    BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer.
    Zhang QF; Li YK; Chen CY; Zhang XD; Cao L; Quan FF; Zeng X; Wang J; Liu J
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32880385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
    J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.
    Schwede M; Waldron L; Mok SC; Wei W; Basunia A; Merritt MA; Mitsiades CS; Parmigiani G; Harrington DP; Quackenbush J; Birrer MJ; Culhane AC
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):509-519. PubMed ID: 31871106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
    Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
    Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
    Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
    Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing acts as an independent prognosticator in ovarian carcinoma.
    Ouyang Y; Xia K; Yang X; Zhang S; Wang L; Ren S; Zhou H; Liu Y; Tang F
    Sci Rep; 2021 May; 11(1):10413. PubMed ID: 34001978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
    Cuello MA; Kato S; Liberona F
    J Cell Mol Med; 2018 Mar; 22(3):1805-1815. PubMed ID: 29266765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.
    Davidson B; Holth A; Hellesylt E; Hadar R; Katz B; Tropé CG; Reich R
    Hum Pathol; 2016 Feb; 48():95-101. PubMed ID: 26640230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.